Objective Evaluation of Untargeted Metabolomic Methods Based on Data-Dependent Acquisition and Public Spectral Databases
Year: 2026
Type: article
Abstract: Untargeted metabolomics based on Ultra High-Performance Liquid Chromatography coupled to High-Resolution Mass Spectrometry (UHPLC-HRMS) is a powerful tool widely used in various research domains, including large-scale clinical studies. However, current approaches for comparing untargeted metabolomic methods typically rely on a limited set of representative analytes due to their high cost and limited availability, potentially introducing bias given the vast chemical diversity of the detectable metabolome. This study proposes a data-driven strategy to systematically compare and rank untargeted UHPLC-HRMS methodologies by leveraging metabolite annotations from the public reference spectral libraries deposited in the Global Natural Products Social molecular network (GNPS) as a proxy for chemical coverage. We assessed 23 methodologies: 15 reverse-phase and 8 HILIC-phase from six metabolomic platforms using commercial human serum samples. Across all methods, a combined total of 2448 unique metabolites were annotated at MSI level 2, covering 57 chemical classes and 13 superclasses, as defined by the ClassyFire ontology. Methods were ranked using a weighted composite system incorporating reproducibility (RSD <30%), linearity (Pearson r > 0.9), and chemical diversity coverage quantified by the Shannon diversity index. The reliability of GNPS-based annotations was validated against 129 metabolites for which authentic standards were available in our in-house library, all of which were correctly confirmed, supporting the reliability of the MSI level 2 annotations. Applied to clinical serum samples from the PrevenDIAB study, the best-performing method combination (P1−H and P6−C18) detected 883 metabolites meeting both quality criteria, of which 98% were shared with the commercial serum results. Our findings demonstrate that this framework provides a practical, scalable, and cost-effective complementary approach to standard-based validation for the comparative evaluation of untargeted metabolomics methods.
Source: Analytical Chemistry
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $4,500
Awards: The Microbial Phenylacetate – host BDK – Branched Chain Amino Acid Axis Controls Glucose Homeostasis, G2178648417, G4103425089, Evaluating Microbiome Causality in the Gut-Liver Axis and Impact on Insulin Resistance, Illuminating the dark metabolome of the human gut microbiome with UHPLC-MS tailored chemometrics and chemoinformatics, G9001398390
OpenAlex ID: W7236788872
